Rajender Aparasu

University of Houston

Affiliations

College of Pharmacy

Pharmaceutical Health Outcomes and Policy

NoneRajender Aparasu is currently serving as a College Of Pharmacy faculty at University of Houston.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Rajender Aparasu

University of Houston

You can click a keyword to filter the displayed items

pharmacology medicine healthcare value geriatrics psychiatry health policy geriatric medicine dementia mental health adolescent health pharmacotherapy geriatric psychiatry older adults depression respiratory medicine united states later adulthood elderly care clinical gerontology child psychiatry psychopharmacology cohort studies child mental health schizophrenia mortality psychotropic medication overactive bladder clinical pharmacology pharmacoepidemiology adolescent medicine attention disorders clinical pharmacy anticholinergic medication use health care disparities drug safety adolescent psychology systematic review antipsychotic agents regional studies neuroscience of aging health care costs elderly patients cardiovascular research intensive care pharmaceutics substance use disease management clinical psychiatry exploratory research comparative effectiveness atypical antipsychotic use retrospective study neuropsychopharmacology experimental gerontology child psychology medicinal research population aging fall prevention medicare beneficiaries pharmacological research pharmaceutical care drug treatment clinical evidence nursing home residents comparative risk elderly outpatients internal medicine youth services prognosis medical decision analysis life prediction pharmaceutical education disease assessment clinical medicine inappropriate prescribing office-based physicians pharmacological issue outcomes research individualized medicine medication safety applied pharmacology adverse drug reaction harm reduction

Notable Scholarly Works

Notable Federal Grants

Collaborators

Adverse Effects Associated With Antipsychotic Use in Older Adults. Expert Opinion on Drug Safety (2024)

Javeria KhalidRajender R. Aparasu

epidemiologygeriatric psychiatrylater adulthoodgeriatricsneuroscience of agingpublic healthpatient safetyolder adultsaddictionsubstance use disordersaddictive behaviorsantipsychotic usepsychotropic medicationaddiction medicinepsychiatrysubstance usedrug safetypsychopharmacologypsychiatric researchadverse effectsgeriatric neurology

Association of Oral Disease-Modifying Agents and Their Adherence Trajectories With Annual Relapses in Multiple Sclerosis. Multiple Sclerosis and Related Disorders (2024)

Jagadeswara Rao EarlaJieni LiGeorge J. HuttonJohn P. BentleyRajender R. Aparasu

neurologymedicinedisease progressionannual relapsesmultiple sclerosisadherence trajectoriessurvival analysisrelapse preventionchronic disease managementoral disease-modifying agentshealth sciences

Co123 Socio-Demographics, Clinical Characteristics, and Quality of Life in Patients With Parkinson’s Disease With and Without Comorbid Insomnia. Value in Health (2024)

S. BhattacharyaS. GoswamiP. SardanaN. AgrawalM. SharmaR. Aparasu

humanitieshealthcare valueinsomniacomorbid insomniaparkinson's diseaseeconomicsvalue theoryquality of lifeclinical characteristicshealth sciences

Comparative Effectiveness of High-Efficacy and Moderate Efficacy Disease-Modifying Agents in Reducing the Annualized Relapse Rates Among Multiple Sclerosis Patients in the United States. Preventive Medicine (2024)

Jieni LiGeorge J HuttonTyler J VariscoYing LinEkere J EssienRajender R Aparasu

public healthmultiple sclerosisrelapse ratesclinical effectivenessmultiple sclerosis patientsrelapse preventionunited statespreventive medicinedisease prevention

Cumulative Anticholinergic Burden and Its Predictors Among Older Adults With Alzheimer’s Disease Initiating Cholinesterase Inhibitors. Drugs & Aging (2024)

Ashna TalwarSatabdi ChatterjeeJeffrey ShererSusan AbughoshMichael JohnsonRajender R. Aparasu

neurologymedicinepharmacologyolder adultsgeriatric medicinelater adulthoodclinical epidemiologygeriatricsalzheimer's diseasecholinesterase inhibitorscumulative anticholinergic burden

Delirium Event and Associated Treatment Modifications Among Older Adults With Alzheimer's Disease: An Interrupted Time‐Series Analysis of Medicare Data. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2024)

Ashna TalwarSatabdi ChatterjeeSusan AbughoshMichael JohnsonJeffrey ShererRajender R. Aparasu

pharmacologyolder adultstreatment modificationspharmacotherapyinterrupted time-series analysisalzheimer's diseasemedicare data

Factors Associated With the Initiation of High-Efficacy Disease-Modifying Agents Over Moderate-Efficacy Disease-Modifying Agents in Multiple Sclerosis. Multiple Sclerosis and Related Disorders (2024)

Jieni LiGeorge J HuttonTyler J VariscoYing LinEkere J EssienRajender R Aparasu

neurologyneurological disordersmultiple sclerosisneuropharmacologyhigh-efficacy disease-modifying agentstherapeutic efficacymoderate-efficacy disease-modifying agents

Factors Associated With the Use of Immune Checkpoint Inhibitors in Older Adults With Metastatic Non-Small Cell Lung Cancer and Pre-Existing Autoimmune Disease: A Seer-Medicare Study. Journal of Geriatric Oncology (2024)

Shrey GohilHua ChenWhitney E LewisMeghana TrivediRajender R AparasuMichael L Johnson

immunologyolder adultsseer-medicare studyimmune checkpoint inhibitorspre-existing autoimmune diseaselung cancer

Infection Risk Associated With High‐Efficacy Disease‐Modifying Agents in Multiple Sclerosis: A Retrospective Cohort Study. Clinical Pharmacology & Therapeutics (2024)

Jieni LiGeorge J. HuttonTyler J. VariscoYing LinEkere J. EssienRajender R. Aparasu

public healthdisease transmissionmultiple sclerosisinfection riskclinical researchhigh-efficacy disease-modifying agentsinfectious diseasesclinical pharmacology

Marginal Health Care Expenditures for Melanoma Care in the United States. Journal of Managed Care & Specialty Pharmacy (2024)

Olajumoke A. OlatejuJieni LiJ. Douglas ThorntonRajender R. Aparasu

public healthmelanomahealth caremarginal health caremelanoma careunited states

1
2
3
4
5
33
10 / page